Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Kirk Randal J
Relationship:   10% Owner
City:   Radford
State:   VA
   
Insider Summary:
  
   
Companies Owned :   6    
Direct Shares   3,684,697    

Indirect Shares

   67,796,291      
Direct Value   $179,101,866    

Indirect Value

   $415,833,338      
Total Shares   71,480,988      
Total Value   $594,935,205      


Halozyme Therapeutics Inc $179,081,245 Alaunos Therapeutics $20,621 Halozyme Therapeutics Inc $179,081,245 Alaunos Therapeutics $20,621
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    14   
    0    

     Stock price went up :
    7   
    0    
     Stock price went down :
    7   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
   48.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Clinical Data Inc CLDA Director, 10% Owner 2011-04-12 0 2011-04-12 0    Premium*  
            Halozyme Therapeutics Inc HALO 10% Owner 2018-08-28 3,562,388 2018-08-28 6,629,464    Premium*  
            Precipio Inc PRPO 10% Owner 2012-02-03 0 2018-08-28 27,151    Premium*  
            Precigen Inc PGEN 0 2024-05-02 51,557,665    Premium*  
            Alaunos Therapeutics TCRT Director, 10% Owner 2015-12-31 122,309 2015-12-31 9,570,094    Premium*  
            Aquabounty Technologies, Inc. AQB 10% Owner 2020-02-13 0 2020-12-17 11,917    Premium*  
* Premium Members only  

Records found :    271         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 9 of 11
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
PGEN Precigen Inc Executive Chairman   •       •       •   2020-03-19 4 B $1.87 $1,098,311 I/I 579,664 10,091,637 2.64 %
HALO Halozyme Therapeutics Inc Director   –       •       •   2007-09-14 4 B $8.71 $1,112,206 I/I 127,693 3,693,406 2.25 -
PGEN Precigen Inc Executive Chairman   •       •       •   2020-03-20 4 B $2.72 $1,143,314 I/I 420,336 10,511,973 2.64 %
PGEN Precigen Inc Director   –       •       •   2021-11-19 4 B $3.75 $1,153,729 I/I 307,661 307,661 2.25 %
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-06-07 4 B $5.26 $1,169,587 I/I 222,355 157,413 2.64 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2011-11-23 4 B $8.00 $1,328,800 I/I 166,100 1,915,947 2.25 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-06-06 4 B $5.23 $1,364,575 I/I 260,913 156,212 2.64 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-05-20 4 B $4.63 $1,396,732 I/I 301,670 918,459 2.64 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2011-11-16 4 B $8.19 $1,437,509 I/I 175,520 1,638,224 2.25 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-05-30 4 B $4.79 $1,473,366 I/I 307,592 153,706 2.64 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2013-08-13 4 A $0.00 $1,501,600 I/I 1,696,140 76,611 0 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2018-08-15 4 S $17.15 $1,569,928 I/I (91,541) 3,041,722 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2013-08-13 4 A $0.00 $1,579,760 I/I 1,880,737 73,668 0 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2011-08-10 4 B $6.13 $1,604,031 I/I 261,669 1,000,000 2.25 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2018-08-16 4 S $17.24 $1,644,058 I/I (95,363) 2,985,054 0 -
PGEN Precigen Inc Executive Chairman   •       •       •   2020-08-12 4 B $4.26 $1,707,689 I/I 400,866 220,123 2.64 %
PGEN Precigen Inc Director   –       •       •   2021-11-23 4 B $3.58 $1,741,079 I/I 486,335 1,000,000 2.25 %
HALO Halozyme Therapeutics Inc Director   –       •       •   2011-11-14 4 B $8.13 $1,788,600 I/I 220,000 1,220,000 2.25 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2018-07-25 4 S $17.32 $1,799,548 I/I (103,900) 3,734,865 0 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2006-12-07 4 B $5.55 $1,865,910 I/I 336,200 1,182,000 1.5 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2018-08-24 4 S $18.20 $1,881,370 I/I (103,372) 2,219,466 0 -
PRPO Precipio Inc 10% Owner   –       –       •   2017-06-08 4 S $1.00 $1,975,000 I/I (1,975,000) 786,613 0 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2011-11-15 4 B $8.18 $1,985,319 I/I 242,704 1,462,704 2.25 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2018-08-27 4 S $18.22 $1,992,849 I/I (109,377) 2,154,470 0 -
CLDA Clinical Data Inc Director   –       •       •   2006-05-18 4 B $20.00 $2,000,000 I/I 100,000 366,246 2.25 -
  271  Records found
  1   2   3   4   5   6   7   8   9  10   11      
  Page 9 of 11  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us